In Response to Karen de Sá’s Article in The San Jose Mercury News

The trauma that children and youth in foster care experience is a serious issue which deserves not only our attention, but our concerted action to eliminate it. A recent article in the San Jose Mercury News (SJMN) suggests that Hillsides and a consulting psychiatrist contributed to this trauma after psychotropic medication was prescribed to a former resident who was discharged from our care eight years ago.

The article insinuates a pattern of unnecessary use of psychotropic medication. In addition, even though children and youth at Hillsides are not recruited to participate in clinical trials, it also suggests that the children might even be participating in clinical trials.

Privacy laws prohibit me from disclosing any medical and personal information about current and former residents of Hillsides. The stories of those in the San Jose Mercury News are examples of the impact traumatic experiences have on children and illustrate how vicarious trauma also affects those adults in their lives.

While the efforts of Karen de Sá, the SJMN reporter, are laudable for drawing attention to a serious matter, it fails to recognize the complex clinical issues challenging residents of programs like Hillsides and as such does a disservice to those residents and those who offer them care.

The typical child referred to a residential treatment program has experienced multiple failed treatment interventions and placements. Often they have been traumatized by family dysfunction, overwhelmed by learning challenges, exposed to multiple failed treatment strategies, and weakened by a fragmented system of care. Vulnerable and desperate, these are the children who often arrive at a residential treatment program with medication already prescribed.

One advantage of a treatment center like Hillsides is that we have the nursing staff and trained counseling personnel to support such vulnerable children. Complex clinical issues are immediately assessed with the hope of engaging all interested parties in the development of a plan for permanent and stabilizing care.

We espouse a cautious approach to the use of psychotropic medication, intentionally mitigating its use in favor of supportive behavioral approaches. At the time of admission, prescribed medications are reviewed, dosage is assessed, and treatment plans are developed to mitigate if not eliminate the use of psychotropic medication. At all times, this process is subject to the practices and regulatory protocols governing the prescribing of medication to a child in the foster care system.

Prescribing psychotropic medication to children, in general, is a serious issue we examine often to ensure that safeguards are in place. As an agency nationally accredited by the Council on Accreditation, we have internal processes in place to review prescription medication.

As I stated to Ms. de Sá in previous correspondence, when medication is prescribed, our healthcare team follows the written approval and authorization process as indicated by the Juvenile Court. In all cases, when a parent retains rights, their consent is required.

Residents, when prescribed psychotropic medication as a last resort, have a diagnosable mental health disorder and also participate in an integrated treatment approach. Our consulting psychiatrists submit a three-page Prescribing Physician Statement to the Juvenile Court. This statement addresses numerous factors from symptoms and treatment alternatives, to the diagnoses from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition and therapeutic services they will participate in.

Consulting psychiatrists follow our guiding philosophy that children and youth will be maintained on the least number of medications possible at the lowest effective dose possible. The Juvenile Court has approved and authorized the psychotropic medication administered to our residents. When prescription medication that requires blood draws is approved by the courts, nursing staff follow all lab protocols to ensure safe use, monitoring, and further assessment. The children and youth are also advised they have a right to refuse medication without fear of consequence, and guardians are notified as well.

Over time, I have seen the complex nature of our clients’ clinical needs escalate. In our residential treatment program, children and youth are diagnosed with severe emotional disturbances and have also experienced traumatic situations that make them unable to live at home for a period of time. Residents receive individual therapy and group counseling, centered on evidence-based practices that are treatment models based on proven research and driven by measurable outcomes.

As I have seen clients’ needs change, so too have I seen child welfare evolve in my 30 years in this field. As child welfare advocates, we review processes, monitor policies, and recommend ways to advance current practice to improve the well-being of children and youth in foster care. The Continuum of Care Reform (AB 403), which took effect in January 2016, calls for a spectrum of services to accelerate the path to permanency for children in foster care, whether through successful reunification or, when appropriate, adoption.

This legislation was informed in part by a pilot program we participated in along with two other residential treatment centers, where children and youth were returned to families in the community in less than a year. We envision that this approach will be the norm moving forward.

As a trauma-informed care provider, we value our residents’ voices and choices. Important to this work is letting them know they can be their own advocates, help them understand the treatment plan, and inform them of why medication is advised and its side effects.

To suggest otherwise is offensive to the staff who provide quality care and underestimates the efforts of our residents and their guardians to heal and improve their lives. I am proud of our healthcare team who give their dedication, specialized care, and heart to the children and youth we serve.

The use of psychotropic medication for children is a serious matter. Hillsides applauds the attention journalists like Ms. de Sá have given to the issue, but we strongly disagree with any insinuation that a course of treatment was used here without regard for the well-being of a child in our care.

Print Friendly, PDF & Email

Avatar
About Joseph M. Costa 7 Articles
Joseph M. Costa is the chief executive officer of Hillsides, a 101-year-old non-profit headquartered in Pasadena that serves families and children in need throughout Los Angeles County. Joe also serves as chairman of the Child Welfare League of America, and is a member of the National Association of Social Workers.